Renal medullary carcinoma: Unsuspected diagnosis at stone protocol CT

被引:2
作者
Neville A. [1 ]
Hatem S.F. [1 ]
机构
[1] Department of Radiology, Cleveland Clinic, Cleveland, OH 44195
关键词
Computed tomography; Renal medullary carcinoma;
D O I
10.1007/s10140-007-0596-y
中图分类号
学科分类号
摘要
Renal medullary carcinoma (RMC) is an aggressive neoplasm occurring almost exclusively in adolescents and young adults with sickle cell (SC) hemoglobinopathies, usually sickle cell trait (SCT) or hemoglobin SC disease. The most common presentations are hematuria and flank or abdominal pain. It is a highly malignant tumor, and responses to chemotherapy are rare and transient resulting in a dismal prognosis. A high level of suspicion is necessary when evaluating at risk patients presenting with hematuria or flank pain, as currently it appears that only early diagnosis could potentially alter the outcome of this disease. We report a case of RMC in a young male patient with SCT, who presented to the emergency department with low back pain and microscopic hematuria, clinically mimicking acute obstructing urolithiasis. Our case emphasizes the need to consider alternate diagnoses when evaluating computed tomography scans for acute flank pain. © 2007 Am Soc Emergency Radiol.
引用
收藏
页码:245 / 247
页数:2
相关论文
共 15 条
  • [1] Koroglu M., Wendel J.D., Ernst R.D., Oto A., Alternative diagnoses to stone disease on unenhanced CT to investigate acute flank pain, Emerg Radiol, 10, pp. 327-333, (2004)
  • [2] Colistro R., Torregiani W.C., Lyburn I.D., Et al., Unenhanced helical CT in the investigation of acute flank pain, Clin Radiol, 57, pp. 435-441, (2002)
  • [3] Talner L., Vaughn M., Nonubstructive renal causes of flank pain: Findings on noncontrast helical CT (CT KUB), Abdom Imaging, 28, pp. 210-216, (2003)
  • [4] Davis C.J., Mostofi F.K., Sesterhenn I.A., Renal medullary carcinoma: The seventh sickle cell nephropathy, Am J Surg Pathol, 19, pp. 1-11, (1995)
  • [5] Swartz M.A., Karth J., Schneider D.T., Rodriguez R., Beckwith J.B., Perlman E.J., Renal medullary carcinoma: Clinical, pathologic, immunohistochemical and genetic analysis with pathogenetic implications, Urology, 60, pp. 1083-1089, (2002)
  • [6] Simpson L., He X., Pins M., Huang X., Campbell S.C., Yang X.J., Et al., Renal medullary carcinoma and ABL Gene amplification, J Urol, 173, pp. 1883-1888, (2005)
  • [7] Strouse J.J., Spevak M., MacK A.K., Arceci R.J., Small D., Loeb D.M., Significant responses to platinum-based chemotherapy in renal medullary carcinoma, Pediatr Blood Cancer, 44, pp. 407-411, (2005)
  • [8] Noguera-Irizarry W.G., Hibshoosh H., Papadopoulos K.P., Renal medullary carcinoma: Case report and review of the literature, Am J Clin Oncol, 26, pp. 489-492, (2003)
  • [9] Blitman N.M., Berkenblit R.G., Rozenblit A.M., Levin T.L., Renal medullary carcinoma: CT and MRI features, AJR Am J Roentgenol, 185, pp. 268-272, (2005)
  • [10] Khan A., Thomas N., Costello B., Jobling L., Dekretser D., Broadfield E., Et al., Renal medullary carcinoma: Sonographic, computed tomography, magnetic resonance and angiographic findings, Eur J Radiol, 35, pp. 1-7, (2000)